Symptoms and signs that might be lung cancer – a new guide to optimal investigation and referral in general practice

Symptoms of lung cancer are often vague and can be overlooked, however, early and rapid investigation and referral is necessary for optimal patient outcomes. How can we give ourselves the best chance of identifying possible lung cancer in our busy primary care practice?

Join us for this GPCE keynote webinar and learn about Cancer Australia’s new resource: ‘Investigating symptoms of lung cancer: a guide for all health professionals.’ You’ll hear from a health professional who is living well with stage 4 lung cancer, as well as expert GPs and a respiratory physician, as they take you step-by-step through this important guide, in a case-based setting.

Learning outcomes

  • Implement recommendations from the resource ‘Investigating symptoms of lung cancer: a guide for all health professionals’ to provide appropriate investigation of adult patients who present to primary care with symptoms that may be lung cancer.
  • Recognise risk factors for lung cancer such as lifestyle, personal, environmental or occupational risk factors, including in different population groups and people who have never smoked
  • Investigate people with symptoms that may be lung cancer within optimal timeframes, and in line with best-practice care.
  • Refer patients to a specialist linked with a multidisciplinary team in a timely way, as a best practice approach to cancer care.

Earn yourself 2 RACGP points or 1 ACRRM CPD hours by participating in this high-impact webinar.

If you are interested in joining the webinar, you can register by clicking the button below.

Speakers

A/Prof Robert Stirling

BSc (Hons), MBBCh (Hons), MRCPI, FRACP, RCPI, MPH

A/Prof Rob Stirling is a full time Respiratory Specialist at The Alfred Hospital (Melbourne) and serves as Steering Committee lead of the Victorian Lung Cancer Registry. Dr Stirling served on the International Consortium for Health Outcomes Measurement (ICHOM) Lung Cancer Working Group and the ICHOM Lung Cancer minimal dataset advisory group and is a current member of the IASLC Quality and Value steering committee.

Dr Kerry Hancock

BMBS (Flin) FRACGP

Dr Hancock is passionate for patients with respiratory conditions to access excellent clinical care by primary care practitioners and to ensure that patients are diagnosed in a timely manner to achieve best outcomes for health and wellbeing. She has been heavily involved in developing primary guidelines and resources for COPD and asthma and is currently Chair RACGP Respiratory Medicine Specific Interest Network. She sits independently on the Lung Cancer Advisory Group for Cancer Australia.

Dr Vivienne Milch

MBBS (Hons), MHPol

Dr Vivienne Milch is Medical Director, at Cancer Australia. In this role, she provides strategic clinical policy input to Cancer Australia’s work to minimise the impact of cancer, address disparities, and improve the health outcomes of people affected by cancer in Australia.

Dr Milch is also medical advisor to the Commonwealth Department of Health on cancer screening policy.

Prior to joining Cancer Australia, Dr Milch was a General Practitioner and clinical researcher at the Garvan Institute of Medical Research, Sydney, and she holds a Masters in Health Policy from the University of Sydney.

Dr Lisa Briggs

Dr Lisa Briggs is an exercise physiologist and osteopath, married with two young children, and living with Stage 4 Lung Cancer. Lisa has become a dedicated lung cancer advocate and public speaker, and is a member of the patient advisory committees of Lung Foundation Australia and Rare Cancers Australia. She is also a consumer representative for Cancer Australia.

Sponsored by

Media Partner